with
clopidogrel which has major implications for the millions of patients currently taking the drug.
Plavix, the brand name of clopidogrel, is the world's second largest-selling drug, with annual sales of $5.9 billion. The study also may impact the concerns over late stent thrombosis that have significantly reduced the use of drug-eluting stents over the past year.
P. Michael Ho, MD, PhD and John S.